Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study
Morales Berstein F, McCartney DL, Lu AT, Tsilidis KK, Bouras E, Haycock P, Burrows K, Phipps AI et al.. eLife, 2022-03-29
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background Epigenetic clocks have been associated with cancer risk in several observational studies. Results Meta-analysed IVW MR findings suggested that higher GrimAge acceleration increased the risk of colorectal cancer (OR = 1.12 per year increase in GrimAge acceleration, 95% CI 1.04-1.20, p = 0.002). Results were less consistent for associations between other epigenetic clocks and cancers. Further work is required to investigate the potential mechanisms underlying the results.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Morales Berstein, F., McCartney, D. L., Lu, A. T., Tsilidis, K. K., Bouras, E., Haycock, P., et al. (2022). Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study. eLife. https://doi.org/10.7554/elife.75374
Vancouver
Morales Berstein F, McCartney DL, Lu AT, Tsilidis KK, Bouras E, Haycock P, et al. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study. eLife. 2022. doi:10.7554/elife.75374. PMID: 35346416.
BibTeX
@article{moralesberstein2022-35346416,
author = {Morales Berstein, F. and McCartney, D. L. and Lu, A. T. and Tsilidis, K. K. and Bouras, E. and Haycock, P. and Burrows, K. and Phipps, A. I. and others},
title = {{Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study}},
journal = {eLife},
year = {2022},
doi = {10.7554/elife.75374},
pmid = {35346416},
url = {https://doi.org/10.7554/elife.75374}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Background Epigenetic clocks have been associated with cancer risk in several observational studies.
- Results Meta-analysed IVW MR findings suggested that higher GrimAge acceleration increased the risk of colorectal cancer (OR = 1.12 per year increase in GrimAge acceleration, 95% CI 1.04-1.20, p = 0.002).
- Results were less consistent for associations between other epigenetic clocks and cancers.
- Further work is required to investigate the potential mechanisms underlying the results.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designmeta-analysis
- Participants34,710
- Effect sizeOR = 1.12; OR = 1.15; OR = 1.05
- Evidence strengthHigh
How this study scored 91/100
Published in a leading specialty journal, and it is a meta-analysis pooling many studies. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 53 of the 58 points we could judge it on, which is 91 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (eLife) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 34,710 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35346416) |
| Free to read | 2 / 2 | Free to read |
| Points | 53 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 53 of the 58 points we could judge it on is 91 out of 100. |
| Total | 91 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.